Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies specific for the melanoma-associated endogenous retrovirus (MERV) envelope glycoprotein

Antibodies specific for the melanoma-associated endogenous retrovirus (MERV) envelope glycoprotein

US Patent 8541553 · Granted Sep 24, 2013

Estimated economic value: $97,988,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Prime-boost influenza vaccine2025
Recombinant high growth rate influenza virus comprising mutations in M1, NS2, an2025
Growth structure for a radiation-emitting semiconductor component, and radiation2025
Electric motor for a handheld power tool2024
Coating material combination consisting of surfacer and topcoat2022
Process for the enzymatic regeneration of redox cofactors2022
Process for the conversion of sugars2022
Method for influenza virus purification2020
Method for obtaining sugar derivatives2020
Influenza virus vector for virotherapy2019
Method for producing a coating consisting of surfacer and topcoat2019
Process for the enzymatic regeneration of redox cofactors2019